| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
0-143 |
Sentence |
denotes |
Nuclear appearance of a factor that binds the CD28 response element within the interleukin-2 enhancer correlates with interleukin-2 production. |
| T1 |
0-143 |
Sentence |
denotes |
Nuclear appearance of a factor that binds the CD28 response element within the interleukin-2 enhancer correlates with interleukin-2 production. |
| T2 |
144-268 |
Sentence |
denotes |
Activation of T lymphocytes requires the combined signaling of the T cell receptor and costimulatory molecules such as CD28. |
| T2 |
144-268 |
Sentence |
denotes |
Activation of T lymphocytes requires the combined signaling of the T cell receptor and costimulatory molecules such as CD28. |
| T3 |
269-379 |
Sentence |
denotes |
The ability of T cells to produce interleukin-2 (IL-2) is a critical control point in T lymphocyte activation. |
| T3 |
269-379 |
Sentence |
denotes |
The ability of T cells to produce interleukin-2 (IL-2) is a critical control point in T lymphocyte activation. |
| T4 |
380-534 |
Sentence |
denotes |
The IL-2 enhancer contains a functional motif named CD28 response element (CD28RE) that serves a role as a target for mitogenic T cell activation signals. |
| T4 |
380-534 |
Sentence |
denotes |
The IL-2 enhancer contains a functional motif named CD28 response element (CD28RE) that serves a role as a target for mitogenic T cell activation signals. |
| T5 |
535-612 |
Sentence |
denotes |
The CD28RE sequence reveals similarity to the consensus kappaB binding motif. |
| T5 |
535-612 |
Sentence |
denotes |
The CD28RE sequence reveals similarity to the consensus kappaB binding motif. |
| T6 |
613-854 |
Sentence |
denotes |
Here we demonstrate that CD28RE binds an inducible protein with a molecular mass of approximately 35 kDa called nuclear factor of mitogenic-activated T cells (NF-MATp35) that is clearly different from the known NF- kappaB/Rel family members. |
| T6 |
613-854 |
Sentence |
denotes |
Here we demonstrate that CD28RE binds an inducible protein with a molecular mass of approximately 35 kDa called nuclear factor of mitogenic-activated T cells (NF-MATp35) that is clearly different from the known NF- kappaB/Rel family members. |
| T7 |
855-1055 |
Sentence |
denotes |
Induction of NF-MATp35 was shown to depend on de novo protein synthesis and was restricted to T cells that received a mitogenic combination of T cell stimuli, not necessarily including CD28 signaling. |
| T7 |
855-1055 |
Sentence |
denotes |
Induction of NF-MATp35 was shown to depend on de novo protein synthesis and was restricted to T cells that received a mitogenic combination of T cell stimuli, not necessarily including CD28 signaling. |
| T8 |
1056-1130 |
Sentence |
denotes |
Nonmitogenic T cell stimulation did not result in appearance of NF-MATp35. |
| T8 |
1056-1130 |
Sentence |
denotes |
Nonmitogenic T cell stimulation did not result in appearance of NF-MATp35. |
| T9 |
1131-1262 |
Sentence |
denotes |
These results indicate that mitogenic combinations of T cell activation signals are integrated at the level of NF-MATp35 induction. |
| T9 |
1131-1262 |
Sentence |
denotes |
These results indicate that mitogenic combinations of T cell activation signals are integrated at the level of NF-MATp35 induction. |
| T10 |
1263-1356 |
Sentence |
denotes |
Similar to its effect on IL-2 production, cyclosporin A inhibited the induction of NF-MATp35. |
| T10 |
1263-1356 |
Sentence |
denotes |
Similar to its effect on IL-2 production, cyclosporin A inhibited the induction of NF-MATp35. |
| T11 |
1357-1592 |
Sentence |
denotes |
Taken together, these data demonstrate that the nuclear appearance of NF-MATp35 shows excellent correlation with IL-2 production, which is a unique characteristic among nuclear factors implicated in the control of IL-2 gene expression. |
| T11 |
1357-1592 |
Sentence |
denotes |
Taken together, these data demonstrate that the nuclear appearance of NF-MATp35 shows excellent correlation with IL-2 production, which is a unique characteristic among nuclear factors implicated in the control of IL-2 gene expression. |